Evidence map›Paper›PMID 33593844›Full record

ArticleAntimicrobial agents and chemotherapy2021

Nicholas P Clayton, Akash Jain, Stephanie A Halasohoris, Lisa M Pysz, Sanae Lembirik, Steven D Zumbrun, Christopher D Kane, Michael J Hackett, Denise Pfefferle, M Autumn Smiley and 4 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Antimicrobial agents and chemotherapy · 2026
    Article
  4. Review
  5. The oral penems and carbapenems.Clinical microbiology reviews · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. The Class A β-Lactamase Produced byAntibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nicholas P ClaytonSpero Therapeutics Inc., Cambridge, MA nclayton@sperotherapeutics.com.ORCID https://orcid.org/0000-0002-6314-8454
Akash JainSpero Therapeutics Inc., Cambridge, MA.
Stephanie A HalasohorisUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
Lisa M PyszUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
Sanae LembirikUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
Steven D ZumbrunUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
Christopher D KaneUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
Michael J HackettBattelle Memorial Institute, Columbus, OH.
Denise PfefferleBattelle Memorial Institute, Columbus, OH.
M Autumn SmileyBattelle Memorial Institute, Columbus, OH.
Michael S AndersonBattelle Memorial Institute, Columbus, OH.
Henry HeineInstitute for Therapeutic Innovation, Department of Medicine, University of Florida, Orlando, FL.
Gabriel T MeisterBattelle Memorial Institute, Columbus, OH.
Michael J PucciSpero Therapeutics Inc., Cambridge, MA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33593844
PMCPMC8092902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.